ASMR

• Single Institution study • Oligometastases, defined as 1–5 sites • N=25, mediam age 69 y. • Period: 2004-2006 • F/u: 17,5 m. • SBRT • Dose: 50 Gy at 5 Gy/fx + sunitinib

• Grade 3 toxicity: 28% • Local control 75% • OS: 71%; PFS: 56%

Tong CC, et al. PLoS One. 2012;7(6):e36979.